GP-1-668: Began Phase I trial in the U.K.

Gensia Inc. (GNSA) Aramed Inc. (ARAM), San Diego Product: GP-1-668, second-generation adenosine regulating agent Indication: Cardio-protection in unstable angina and acute myocardial infarction, and/...